LMBR1L
protein-codinglimb development membrane protein 1 like
Gene summary
Enables transmembrane signaling receptor activity. Involved in receptor-mediated endocytosis and signal transduction. Located in endoplasmic reticulum membrane and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~13.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LMBR1L variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018113.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 2 | 67 | 1 | 70 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 2 | 71 | 1 | 0 | 74 |
Highest pathogenic variant AF is 0.000049561382
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060583.2 | 17 | MANE Select | |
| Ensembl | ENSP00000267102.8 | 17 | MANE Select | |
| RefSeq | NP_001287679.1 | 16 | Standard | |
| RefSeq | NP_001287680.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- receptor-mediated endocytosis
- signal transduction
Molecular Function
- transmembrane signaling receptor activity
- protein binding
Cellular Component
- plasma membrane
- integral component of plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000267102
- Coding exons
- 17
- Length
- 13765
- Individuals with no LoFs
- 125592
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 155
- Defined
- 125748
- p
- 0.000620
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.781 | 243 | 280 | 0.869 | 0.0000157 | 3104 |
| Missense (PolyPhen) | 95 | 114.98 | 0.82622 | 1371 | ||
| Synonymous | -0.733 | 126 | 116 | 1.09 | 0.00000605 | 1052 |
| Loss of Function | 1.27 | 23 | 30.6 | 0.753 | 0.00000154 | 330 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00049 | 0.00049 | rare |
| Finnish | 0.00056 | 0.00055 | rare |
| European (Non-Finnish) | 0.00091 | 0.00089 | rare |
| South Asian | 0.00052 | 0.00052 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable LCN1 receptor. May mediate LCN1 endocytosis. {ECO:0000269|PubMed:11287427, ECO:0000269|PubMed:12591932}.;
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- LoFtool
- 0.805
- RVIS EVS
- -0.65
- RVIS percentile EVS
- 16.44
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.108
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |